| abstract |
The invention belongs to the technical field of medicines, and specifically relates to a primary alkylate derivative of Vibralactone (Formula I), a pharmaceutical composition comprising a compound represented by General Formula I or a pharmaceutically acceptable salt thereof as an active ingredient , their preparation methods, and their application in the preparation of medicaments for the prevention and treatment of obesity and other metabolic diseases such as diabetes. |